Trial intelligence / Profile preview

CORONACION: ACEi/ARB Safety in COVID-19

NCT04330300Phase 4Suspended

Sponsor
University of Galway
Start
Apr 2020
Primary completion
Jul 2021
Countries
1
01

Overview

Phase 4, randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by University of Galway. Primary endpoint: Number of Covid-19 positive participants who die, require intubation in ICU, or require hospitalization for non-invasive ventilation (NIV) at 12 months. Started Apr 2020; status: suspended.

02

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT04330300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04330300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call